UNII U725QWY32X

POVIDONE K30

Unique Ingredient Identifier U725QWY32X is listed as a ingredient substance
UniiU725QWY32X
Legacy Unii390RMW2PEQ
Preferred Substance NamePOVIDONE K30
Rn9003-39-8
NcitC82262
Rxcui1297406
Unii TypeINGREDIENT SUBSTANCE
RN9003-39-8
NCITC82262
RXCUI1297406
MFPolymer substance not supported

Alternate Names

Dosage Forms

UNII U725QWY32X POVIDONE K30 is commonly included in medications in the following forms.

RouteDosage FormPotency
AURICULAR (OTIC)SOLUTION, DROPS0.2 %
BUCCALTABLET, EXTENDED RELEASE0.5 MG
OPHTHALMICSOLUTION150 MG/1ML
OPHTHALMICSOLUTION2 %
OPHTHALMICSOLUTION, DROPS2 %
OPHTHALMICSOLUTION, DROPS1.8 %W/V
OPHTHALMICSUSPENSION0.6 %
ORALCAPSULE61.5 MG
ORALCAPSULE (IMMED./COMP. RELEASE), HARD GELATIN16 MG
ORALCAPSULE, COATED, SOFT GELATIN5 MG
ORALCAPSULE, DELAYED ACTION12.38 MG
ORALCAPSULE, DELAYED RELEASE8.06 MG
ORALCAPSULE, EXTENDED RELEASE82.18 MG
ORALCAPSULE, SOFT GELATIN30 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED25.2 MG
ORALCAPSULE, SUSTAINED ACTION10.05 MG
ORALCAPSULE, SUSTAINED ACTION, HARD GELATIN41.7 MG
ORALDISPERSIBLE TABLET84 MG
ORALGRANULE201.63 MG/1PKT
ORALGRANULE16.4 mg
ORALGRANULE, EFFERVESCENT NA
ORALLIQUID30 MG/1ML
ORALLIQUID,EXTENDED RELEASE1.03 MG/ML
ORALLOZENGE35 mg
ORALPELLET3 MG
ORALPOWDER18 MG/SACHET
ORALPOWDER FOR ORAL SOLUTION DOSAGE FORM5 mg
ORALPOWDER, FOR ORAL SOLUTION5 MG
ORALPOWDER, FOR SUSPENSION13 MG/5ML
ORALSOLUTION30.5 MG/1ML
ORALSOLUTION5 MG/SACHET
ORALSUSPENSION18.5 MG/5ML
ORALTABLET94 mg
ORALTABLET (IMMED./COMP. RELEASE), COATED8 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED12.5 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE10 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESC40 MG
ORALTABLET, CHEWABLE8.18 MG
ORALTABLET, COATED21 MG
ORALTABLET, CONTROLLED RELEASE20.5 MG
ORALTABLET, DELAYED ACTION50 MG
ORALTABLET, DELAYED ACTION, COATED35 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED27.2 MG
ORALTABLET, DELAYED RELEASE40.11 MG
ORALTABLET, DISPERSIBLE3 MG
ORALTABLET, ENTERIC COATED PARTICLES18.6 MG
ORALTABLET, EXTENDED RELEASE90 mg
ORALTABLET, FILM COATED75 MG
ORALTABLET, MULTILAYER, COATED15 MG
ORALTABLET, ORALLY DISINTEGRATING35.71 MG
ORALTABLET, SUSTAINED ACTION60 MG
ORALTABLET, SUSTAINED ACTION, COATED16 MG
SUBLINGUALFILM2.3 mg
SUBLINGUALTABLET10 MG
SUBLINGUALTABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL8 MG
TOPICALEMULSION, AEROSOL FOAM1.9 %W/W
TOPICALPATCH, CONTROLLED RELEASE NA
TRANSDERMALFILM5.11 MG
TRANSDERMALFILM, CONTROLLED RELEASE7.27 MG
TRANSDERMALPATCH5.48 mg
VAGINALTABLET50 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.